Skip to content

Zoetis ZTS Total Equity

Total Equity at other companies

Merck & Co. logo
Merck & Co.MRK
$45.88B-5.1%
Neogen logo
NeogenNEOG
$2.1B-21.0%
Idexx Laboratories logo
Idexx LaboratoriesIDXX
$1.56B+7.5%
Phibro Animal Health logo
Phibro Animal HealthPAHC
$361.83M+36.0%
Elanco Animal Health Inc. logo
Elanco Animal Health Inc.ELAN
$6.5B+2.3%
Tractor Supply Company logo
Tractor Supply CompanyTSCO
$2.51B+12.3%

Other financials

Income statement

See full
Revenue$2.3B+2.9%
Gross profit$1.6B+2.6%
Net income$601.0M-0.2%
EPS (diluted)$1.42+6.0%

Balance sheet

See full
Cash & equivalents$1.9B+8.9%
Total debt$10.0B+48.0%
Total assets$15.2B+7.5%

Cash flow

See full
Operating cash flow$401.0M-22.1%
CapEx$110.0M-38.2%
Free cash flow$291.0M-13.6%

Valuation

See full
Market cap$31.9B-54.6%
Enterprise value$39.95B-47.2%
P/E12.1×-15.1×
P/S3.4×-4.1×

Profitability

See full
Gross margin71.8%+0.8pp
Net margin27.8%+0.9pp
FCF margin23.5%0.0pp

Returns & leverage

See full
Return on equity67%+15.8pp
Debt / equity3.1×+1.6×
Current ratio3.2×+1.4×

Where this comes from

Reported directly by Zoetis in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Zoetis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zoetis's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zoetis's total equity?
Zoetis (ZTS) reported total equity of $3.23B in Q1 2026.
How has Zoetis's total equity changed year-over-year?
Zoetis's total equity decreased by 30.5% year-over-year, from $4.66B to $3.23B.
What is the long-term trend for Zoetis's total equity?
Over 5 years (2020 to 2025), Zoetis's total equity has grown at a -2.0% compound annual growth rate (CAGR), from $3.77B to $3.42B.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.